Mast Cell Disease: What It Is, Why It Happens, and How to Navigate It(Including Dr. Afrin’s Key Insights & Consensus Criteria)
- Girl In A Bubble
- Sep 25
- 4 min read
What Is a Mast Cell & What Is Its Normal Function
Mast cells are immune cells found throughout the body (skin, lungs, gut, blood vessels, nerves). They are sentinels always sensing the environment. IFM+2The ME Association+2
When there’s injury, infection, or allergen, mast cells release mediators (signaling chemicals) like histamine, tryptase, prostaglandins, etc., to help trigger inflammation, recruit other immune cells, help with healing and defense. Afrin emphasizes they respond very rapidly, sub-second in many cases, compared to other immune cells. The ME Association+1
When Mast Cells Go Astray
Instead of releasing mediators appropriately, mast cells can misbehave: they may over-release, release at wrong times, wrong places, or in wrong amounts. That leads to inflammation, multiple organ/systems involvement, allergic-like symptoms, etc. Afrin points out that many different mediators (not just histamine & tryptase) are involved and that variation largely explains why symptoms are so diverse. IFM+2The ME Association+2
There are two broad classes of problems:
Mastocytosis: abnormal growth or accumulation of mast cells (sometimes due to genetic mutations)
Mast cell activation disorders, especially Mast Cell Activation Syndrome (MCAS): more about abnormal activation rather than huge overgrowth. Afrin and others have been refining how to recognize MCAS. Mast Cell Action+2The ME Association+2
What Causes It According to Afrin & Other Experts
Genetic mutations or changes may play a role in some patients. The ME Association+2WJGNet+2
Environmental triggers can activate mast cells excessively: allergens, infections, stress (physical and emotional), certain foods, medications, temperature changes, etc. Afrin notes that the pathology of MCAS likely involves both constitutive (baseline) and reactive activation of mast cells. IFM+2EDS GP Toolkit+2
In many cases, it’s not one cause but multiple interacting factors. Afrin’s work points out that the disease’s variability arises from differences in which mediators, how many mast cells, where in the body, genetic predisposition, etc. IFM+1
Diagnosis (With Dr. Afrin’s Criteria / Consensus Guidelines)
Dr. Afrin has helped develop and uses diagnostic criteria, especially what's called “Consensus-2” for MCAS. Here are key points:
Diagnostic Element | What to Look for |
History & Symptoms | Recurrent or chronic symptoms consistent with mast cell mediator excess: allergic-type symptoms, gastrointestinal, cardiovascular (flushing, palpitations, hypotension etc.), skin symptoms, respiratory, etc. Patterns that are migratory, waxing/waning. Mast Cell Action+2WJGNet+2 |
Laboratory Evidence | Elevated levels of mast cell mediators (e.g. histamine, tryptase, prostaglandins, leukotrienes) in blood or urine during symptoms. Note: normal mediator levels when asymptomatic do not rule out disease. Mast Cell Action+2IFM+2 |
Biopsy / Tissue Evidence (Optional / Supportive) | Sometimes biopsies (skin, GI, bone marrow) show increased numbers of mast cells. But Afrin emphasizes you don’t always need biopsy evidence if other criteria are met. IFM+1 |
Response to Treatment | Some improvement when using mast cell–targeted therapies (antihistamines, mast cell stabilizers) supports the diagnosis. IFM+1 |
Exclude Other Diseases | Rule out other causes that could better explain the symptoms. Mast Cell Action |
According to Consensus-2 (Afrin et al., 2020), diagnosis of MCAS is valid if criteria are met, even if not all are present, provided other causes are excluded. Mast Cell Action
Treatments & Management (Including Dr. Afrin’s Strategy)
Antihistamines: Both H1 (for skin, itching, etc.) and H2 blockers (for stomach, cardiovascular effects) are first-line in many cases. Afrin says these are relatively safe, cheap, and often helpful. IFM
Mast cell stabilizers: Drugs that reduce the ability of mast cells to degranulate (release mediators).
Other mediator blockers: Depending on which mediators are involved (leukotriene blockers, prostaglandin inhibitors, etc.).
Emergency treatments: Epinephrine auto-injectors if risk of anaphylaxis; also carry medical alert info.
Lifestyle & Support Measures: Avoid known triggers; careful diet; managing stress; environmental controls; temperature regulation. Afrin emphasizes that each patient’s “cocktail” of treatments (drugs + trigger avoidance + supportive measures) is often necessary, because of how variable the disease is. IFM+1
Things to Avoid & Why
Because mast cells are sensitive, avoiding triggers is an essential part of managing disease:
Foods high in histamine or that trigger histamine release (aged foods, alcohol, certain fish, cheeses etc.)
Certain medications: NSAIDs, opioids, some contrast dyes, etc.
Strong scents, perfumes, harsh chemicals
Extremes of temperature, hot showers, sun exposure
Physical trauma, friction, pressure, vibration of skin
Emotional and physical stress
Infections or anything that can provoke immune responses
These avoidances help prevent or reduce triggering mast cell activation, which reduces symptoms. Afrin notes that patients often need to track their symptom patterns and triggers carefully. EDS GP Toolkit+2IFM+2
Afrin’s Philosophy: Key Takeaways & Hope
Although MCAS and related mast cell activation disorders are complex and biological understanding is still emerging, many patients can improve significantly with correct diagnosis and treatment. IFM+1
It's often not sufficient to rely only on symptoms; lab evidence and exclusion of other causes are valuable both for accurate diagnosis and for convincing treating/primary doctors. Afrin stresses the importance of being able to show evidence to clinicians who may be unfamiliar with MCAS. IFM+1
Patience and persistence: finding the right combination of therapies (“cocktail”) often takes time (weeks to months) and trial & error. Discard treatments that don’t help you significantly after a month or so. IFM
Final Thoughts
Mast cell disease especially MCAS is a multifaceted disorder involving over-responsive immune mediators rather than just overgrowth. Dr. Afrin’s work helps clarify criteria for diagnosis, gives hope for treatment, and emphasizes that though the disease may feel overwhelming, many strategies (medical + lifestyle) exist to reduce symptoms and improve quality of life.
If you or someone you know might have mast cell disease:
Keep a detailed symptom diary.
Find doctors willing to explore MCAS and do the necessary labs.
Identify likely triggers and avoid them.
Start simple treatments (antihistamines etc.), and adjust based on response.
Posted By
The Original "Girl In A Bubble


Comments